Aiello Joshua 4

Accession 0001213900-23-006191

CIK 0001814114other

View on SEC.gov Company Profile

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 9:32 PM ET

Size

17.4 KB

Accession

0001213900-23-006191

Insider Transaction Report

Form 4

Period: 2023-01-26

Orchestra BioMed Holdings, Inc.OBIO

Aiello Joshua

Principal Accounting Officer

Transactions

Award
Nonstatutory Stock Option (Right to Buy)
2023-01-26+6,975→ 6,975 total
Exercise: $7.66Exp: 2030-10-13→ Common Stock (6,975 underlying)
Award
Nonstatutory Stock Option (Right to Buy)
2023-01-26+4,650→ 4,650 total
Exercise: $4.06Exp: 2032-04-11→ Common Stock (4,650 underlying)
Award
Nonstatutory Stock Option (Right to Buy)
2023-01-26+6,975→ 6,975 total
Exercise: $4.30From: 2023-01-26Exp: 2029-08-06→ Common Stock (6,975 underlying)
Award
Nonstatutory Stock Option (Right to Buy)
2023-01-26+4,185→ 4,185 total
Exercise: $4.75Exp: 2031-08-04→ Common Stock (4,185 underlying)
Award
Nonstatutory Stock Option (Right to Buy)
2023-01-26+18,228→ 18,228 total
Exercise: $10.00Exp: 2032-08-25→ Common Stock (18,228 underlying)

Footnotes (9)

[F1]These securities were received on the closing date of the merger (the "Business Combination") contemplated by the Agreement and Plan of Merger, dated as of July 4, 2022, as amended by Amendment No. 1 thereto dated as of July 21, 2022 and Amendment No. 2 thereto dated as of November 21, 2022 (as amended, the "Merger Agreement"), by and among Orchestra BioMed Holdings, Inc. (f/k/a Health Sciences Acquisitions Corporation 2) ("HSAC2"), HSAC Olympus Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HSAC2, and Orchestra BioMed, Inc., a Delaware corporation ("Legacy Orchestra"), in exchange for a nonstatutory stock option to acquire 15,000 shares of common stock of Legacy Orchestra Legacy Orchestra ("Legacy Orchestra Common Stock") for $2.00 per share.
[F2]The nonstatutory stock options ("NSOs") have vested and will vest in equal installments over a three-year period on a monthly basis, on the day of the month of each month that is the same day of the month as the grant date, starting with the first month after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is October 14, 2020.
[F3]Received in the Business Combination in exchange for a nonstatutory stock option to acquire 15,000 shares of Legacy Orchestra Common Stock for $3.56 per share.
[F4]The NSOs have vested and will vest in equal installments over a three-year period on a monthly basis, on the day of the month of each month that is the same day of the month as the grant date, starting with the first month after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is August 5, 2021.
[F5]Received in the Business Combination in exchange for a nonstatutory stock option to acquire 9,000 shares of Legacy Orchestra Common Stock for $2.21 per share.
[F6]The incentive stock options vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis, on the day of the month of each quarter that is the same day of the month as the grant date, starting with the corresponding date in the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is April 12, 2022.
[F7]Received in the Business Combination in exchange for an incentive stock option to acquire 10,000 shares of Legacy Orchestra Common Stock for $1.89 per share.
[F8]The incentive stock options vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the day of the month of each quarter that is the same day of the month as the grant date, starting with the corresponding date in the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is August 18, 2022.
[F9]Received in the Business Combination in exchange for an incentive stock option to acquire 39,200 shares of Legacy Orchestra Common Stock for $4.65 per share.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Orchestra BioMed Holdings, Inc.

CIK 0001814114

→

Entity typeother

Related Parties

filerCIK 0001960418

Filing Metadata

Form type: 4
Filed: Jan 29, 7:00 PM ET
Accepted: Jan 30, 9:32 PM ET
Size: 17.4 KB

View on SEC.gov